Triple antiplatelet therapy vs. dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: an evidence-based approach to answering a clinical query

AIMS: Outcomes of patients undergoing percutaneous coronary intervention (PCI) with drug-eluting stents (DES) and bare metal stents (BMS) have not been evaluated separately for specific dual and triple antiplatelet agent use. The purpose of this meta-analysis was to determine whether triple antiplat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Singh, Inderjeet, Shafiq, Nusrat, Pandhi, Promila, Reddy, Srinivas, Pattanaik, Smita, Sharma, Yashpaul, Malhotra, Samir
Formato: Artigo
Lenguaje:Inglês
Publicado: Blackwell Science Inc 2009
Materias:
Meta-Analysis
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2732935/
https://ncbi.nlm.nih.gov/pubmed/19659998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2009.03402.x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares